Clinical significance of intrinsic factor antibody assay
Abe, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 584-586
1990
ISSN/ISBN: 0047-1852 PMID: 2355581 Document Number: 354433
Document emailed within 1 workday
Related Documents
Li, R.S.; Zhang, Z.N.; Yang, J.Y. 1988: Significance of intrinsic factor blocking antibody in serum Zhonghua Nei Ke Za Zhi 27(10): 638Handa, M.; Hirano, T.; Ikeda, Y. 1990: Clinical significance of antiplatelet antibody assay Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 529-532
Ito, H. 1990: Clinical significance of anti-reticulin antibody assay Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 627-629
Mori, T. 1985: Antireceptor antibody assay--methods and clinical significance Rinsho Byori. Japanese Journal of Clinical Pathology 33(4): 390-395
Sekiguchi, S. 1990: Clinical significance of anti-ribosome antibody assay Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 619
Mimori, T.; Hama, N.; Suwa, A. 1990: Clinical significance of anti-histone antibody assay Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 587-591
Nakamura, Y.; Takahashi, T.; Niwa, A. 1990: Clinical significance of anti-vimentin antibody assay Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 509-512
Sekiguchi, S. 1990: Clinical significance of anti-lymphocyte antibody assay Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 620-623
Ohi, H.; Sakamoto, K.; Hatano, M. 1990: Clinical significance of anti-brush border antibody assay Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 554-556
Nakagawa, C.; Tsukahara, T.; Shimatake, H. 1990: Clinical significance of anti human N-myc protein antibody assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 942-945
Kano, Y.; Oda, M. 2010: Anti-intrinsic factor antibody Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 6): 605-607
Hirata, Y. 1990: Assay of epidermal growth factor in body fluids and the clinical significance Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 145-150
Sugihara, T.; Saito, H. 1987: Application of a monoclonal antibody against factor XIi (Hageman factor); enzyme-linked immunosorbent assay (ELISA) for factor XIi antigen Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(3): 691-695
Wolff, R.; Nicolas, J.P.; Jeanmaire, N. 1973: Detection and semi-quantitative biological determination of the antigenic determinants of human gastric intrinsic factor (I.F.) and anti-intrinsic factor in autoantibodies in pathological sera Annales de Biologie Clinique 31(3): 193-201
Amarapurkar, D.N.; Amarapurkar, A.D. 2010: Intrinsic factor antibody negative atrophic gastritis; is it different from pernicious anaemia? Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 266-270
Fairbanks, V.F.; Lennon, V.A.; Kokmen, E.; Howard, F.M. 1983: Tests for pernicious anemia: serum intrinsic factor blocking antibody Mayo Clinic Proceedings 58(3): 203-204
Rothenberg, S.P.; Kantha, K.R.; Ficarra, A. 1971: Autoantibodies to intrinsic factor: their determination and clinical usefulness Journal of Laboratory and Clinical Medicine 77(3): 476-484
Kaku, K.; Harada, Y.; Kaneko, T. 1990: Clinical significance of cyclic GMP assay Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 138-140
Masuno, T. 1990: Clinical significance of interleukin-4 assay Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 814-817
Kara, I.Oguz.; Sahin, B.; Gunesacar, R.; Unsal, C. 2006: Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma Advances in Therapy 23(4): 635-645